Pathogenic Insights and Search for Biomarkers in RFC1-ataxia/CANVAS
Recruiting
N/A
Interventional Study
CANVAS Syndrome
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 – 80
- Sex
- Any
- Study type
- Interventional
- Purpose
- Basic Science
- Participants needed
- 50 (estimated)
- Sponsor
- Catholic University of the Sacred Heart · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
CANVAS (Cerebellar Ataxia, Neuropathy, Vestibular Areflexia Syndrome), also referred to as RFC1-ataxia, is a recently molecularly characterized neurodegenerative disorder caused by a biallelic expansion of an AAGGG pentanucleotide repeat in intron 2 of the Replication Factor C subunit 1 (RFC1) gene.
This adult-onset condition presents with a variable combination of cerebellar ataxia, peripheral n…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Molecular diagnosis of RFC1-ataxia
* age \>18 years and \<80 years
* ability to sign informed consent
Exclusion Criteria:
* Diagnosis of other degenerative and/or non-degenerative neurological diseases
* Not signed informed consent
Contacts